Author/Authors :
Sardari, Soroush Drug Design and Bioinformatics Unit - Medical Biotechnology Department - Biotechnoloogy Research Center - Pasteur Institute of Iran, Tehran, Iran , Feizi, Samaneh Drug Design and Bioinformatics Unit - Medical Biotechnology Department - Biotechnoloogy Research Center - Pasteur Institute of Iran, Tehran, Iran , Rezayan, Ali Hossein Department of Life Science Engineering - Faculty of New Sciences & Technologies - University of Tehran, Tehran, Iran , Azerang, Parisa Drug Design and Bioinformatics Unit - Medical Biotechnology Department - Biotechnoloogy Research Center - Pasteur Institute of Iran, Tehran, Iran , Shahcheragh, mohammad Drug Design and Bioinformatics Unit - Medical Biotechnology Department - Biotechnoloogy Research Center - Pasteur Institute of Iran, Tehran, Iran , Ghavami, Ghazaleh Drug Design and Bioinformatics Unit - Medical Biotechnology Department - Biotechnoloogy Research Center - Pasteur Institute of Iran, Tehran, Iran , Habibi, Azizollah Faculty of Chemistry - Kharazmi University, Tehran, Iran
Abstract :
Thiosemicarbazides are potent intermediates for the synthesis of pharmaceutical and
bioactive materials and thus, they are used extensively in the field of medicinal chemistry. The
imine bond (-N=CH-) in this compounds are useful in organic synthesis, in particular for the
preparation of heterocycles and non-natural β-aminoacids. In this paper the synthesis of some
new thiosemicarbazide derivatives by condensation reaction of various aldehydes or ketones
with 4-phenylthiosemicarbazide or thiosemicarbazide is reported. This synthesis method has
the advantages of high yields and good bioactivity. The structures of these compounds were
confirmed by IR, mass, 1H NMR, 13C NMR, and single-crystal X-ray diffraction studies. All
of these compounds were tested for their in-vitro anti-mycobacterial activity. The influence
of the functional group and position of substituent on anti-bacterial activity of compounds is
investigated too. The preliminary results indicated that all of the tested compounds showed
good activity against the test organism. The compounds 11 and 30 showed the highest antitubercular
activity (0.39 μg/mL). This synthesis method has the advantages of high yields and
good bioactivity.
Keywords :
Medicinal chemistry , Anti-tubercular activity , Mycobacterium bovis , Mycobacterium bovis , Biological evaluation , Thiosemicarbazide derivatives